Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

An Experimental Ebola Vaccine Just Took A Giant Leap Forward

Devan Joseph,Associated PressNov 29, 2014, 23:58 IST

Your browser doesn't support HTML5 video.

kalturavideoplaceholder

The National Institutes of Health's initial trial found the experimental vaccine for the Ebola virus so far is safe for humans and produced an immune response. Researches found anti-Ebola antibodies in the blood of all 20 healthy adult volunteers. The findings mean the potential vaccine can move to the next phase of testing, which could involve thousands of participants and could start early next year.

The trial vaccine includes genetic material from two Ebola strains, including the one fueling the deadly outbreak in West Africa, which has now infected nearly 16-thousand people.

Produced by Devan Joseph. Video courtesy of Associated Press.

Follow BI Video: On Facebook